Analysis Pharming Group NV (PHGUF)
6/2/2024
Analysis of Pharming Group NV (PHGUF)
Pharming Group NV (PHGUF) has shown a consistent price close around 0.95400 over the past several days. The Relative Strength Index (RSI) indicator has been relatively low, indicating potential oversold conditions.The Moving Average Convergence Divergence (MACD) indicator has been negative, with the MACD line below the signal line. However, the MACD histogram has shown some positive values, suggesting a possible reversal in the short term.
The Moving Average (MA) indicator has been above the current price, indicating a bearish trend. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have all been above the current price as well.
Overall, the technical indicators suggest a bearish sentiment for Pharming Group NV in the short term, with potential for a reversal based on the MACD histogram. Traders and investors may want to monitor the RSI and MACD indicators for signs of a trend reversal.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow TTM of $110.56 billion and levered free cash flow TTM of $84.73 billion. The balance sheet shows total cash MRQ of $67.15 billion, total debt MRQ of $104.59 billion, and a current ratio MRQ of 1.037. The profit margin is 26.31%, with a fiscal year ending on September 30, 2023. The income statement reveals EBITDA of $131.39 billion, revenue TTM of $381.62 billion, and a diluted EPS TTM of $6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares short. The average 10-day volume is 46.86 million, while the average 90-day volume is 57.50 million. The company has 15.33 billion shares outstanding, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book MRQ of 39.34 and price to sales TTM of 7.65. The enterprise to EBITDA ratio is 22.76, and the enterprise to revenue ratio is 7.73. The market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.26, a 50-day moving average of $176.26, a 200-day moving average of $181.04, a 52-week low of $164.08, a 52-week high of $199.62, and a 52-week change of 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date of May 16, 2024, and an ex-dividend date of May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, showing a healthy growth in profitability.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years, indicating growth in shareholder value.
7. The company has been able to maintain a stable number of outstanding shares, which is important for EPS calculations.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in non-current assets, which could indicate growth and expansion strategies.
7. There is a consistent level of short-term debt and accounts payable over the years.
8. The company has been managing its long-term debt and non-current liabilities effectively.
9. Retained earnings have been fluctuating, suggesting variations in profitability or dividend policies.
10. Overall, the company seems to be in a stable financial position with a focus on growth and maintaining a healthy balance between assets and liabilities.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This represents an increase from the EPS of $1.17 reported a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 reported in the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This shows growth from the EPS of $5.67 reported in the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 expected for the current fiscal year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, and analysts expect this growth to continue at a slightly lower but still healthy rate in the coming years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, suggesting that there may be potential for growth according to the analysts' predictions.
MACD of PHGUF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
